Immunohistochemical detection of c-erbB-2 oncoprotein in patients with breast cancer

Journal of the Medical Association of Thailand

Volumn 79, Issue 11, 1996, Pages

  Chariyalertsak, Sunanta ^a   Cheirsilpa, Arkom ^a   Chariyalertsak, Suwat ^b   Sugano, Kokichi ^c   Ohkura, Hisanao ^c  

^a NATIONAL CANCER INSTITUTE   (Thailand)

^b Faculty of Medicine Chiang Mai University   (Thailand)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 17744408783     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Schechter AL, Hung MC, Vaidyanathan L. The neu oncogene and erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 1985; 229: 976-8,
2. Fukushige S, Matsubara K, Yoshida M. Localization of a novel V-erbB-related gene, c-erbB-2, on human chromosome-17 and its amplification in gastric cancer cell line. Mol Cell Biol 1986; 6: 955-8.
3. Bargmann CI, Hung MC, Weinberg RA. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 1986; 319: 226-30.
4. Yamamoto T, IKawa S, Akiyama T, et al. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor. Nature 1986; 319: 230-4.
5. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer : correlation of relapse and survival with amplification of the HER-2 / neu oncogene. Science 1987; 235: 177-82.
6. Zhou D, Battifora H, Yokota J, Yamamoto T, Cline MJ. Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer. Cancer Res 1987; 47: 6123-5.
7. Wright C, Angus B, Nicholson S, et al. Expression of c-erbB-2 oncoprotein : a prognostic indicator in human breast cancer. Cancer Res 1989; 49: 2087-90.
8. Tandon AK, Clark GM, Chamness GC, Ullrich A, McGuire WL. HER-2 / neu oncogene protein and prognosis in breast cancer. J Clin Oncol 1989; 7: 1120-8.
9. Borg A, Tandon AK, Sigurdsson H, et al. HER -2/ neu amplification predicts poor survival in node-positive breast cancer. Cancer Res 1990; 50: 4332-7.
10. Paterson MC, Dietrich KD, Danyluk J, et al. Correlation between c-erbB-2 amplification and risk of recurrent disease in node - negative breast cancer. Cancer Res 1991; 51: 556-67.
11. Pavelic ZP, Pavelic L, Lower EE, et al. c-myc, c-erbB-2 and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma. Cancer Res 1992; 52: 2597-602.
12. Tsuda H, Hirohashi S, Shimosato Y, et al. Immuno- histochemical study on overexpression of c-ereB-2 protein in human breast cancer : its correlation with gene amplification and long-term survival of patients. Jpn J Cancer Res 1990; 81: 327-32.
13. Soomro S, Taylor P, Shepard HM, Feldmann M, Sinnen HD, Shousha S. c-ereB-2 oncoprotein in screen-detected breast carcinoma : an immunohistochemical study. Int J Cancer 1993; 55: 63-5.
14. Chariyalertsak S. Estrogen and progesterone receptors in breast cancer : incidence and clinical correlations in Thai patients. Bull Dept Med Serv 1987; 12: 263-7.
15. Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T. The product of the human c-erbB-2 gene : a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 1986; 232: 1644-6.
16. Yamada Y, Yoshimoto M, Murayama Y, et al. Association of elevated expression of the c-erbB-2 protein with spread of breast cancer. Jpn J Cancer Res 1989; 80: 1192-8.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
18. Peto R, Pike MC, Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
19. Fontaine J, Tesseraux M, Klein V, Basten G, Blin N. Gene amplification and expression of the neu (c-erbB-2) sequence in human mammary carcinoma. Oncology 1988; 45: 360-3.
20. Berns EMJJ, Klijn JGM, Van Putten WLJ, Van Staveren IL, Portengen H, Foekens JA. c-myc amplification is a better prognostic factor than HER 2/ neu amplification in primary breast cancer. Cancer Res 1992; 52: 1107-13.
21. Venter DJ, Tuzi NL, Kumar S, Gullick WJ. Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlated with gene amplification. Lancet 1987; 2: 69-72.
22. Van de Vijver MJ, Mooi WJ, Wisman P, Peterse JL, Nusse R. Immunohistochemical detection of the neu protein in tissue sections of human breast tumors with amplified neu DNA. Oncogene 1988; 2: 175-8.
23. Seshadri R, Matthews C, Dobrovic A, Horsfall DJ. The significance of oncogene amplification in primary breast cancer. Int J Cancer 1989; 43: 270-2.
24. Rio MC, Bellocq JP, Gairard B, et al. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of their estrogen and progesterone receptors and the oncogene ERBB2. Proc Natl Acad Sci USA 1987; 84: 9243-7.
25. Cline MJ, Battifora H, Yokota J. Proto-oncogene abnormalities in human breast cancer correlation with anatomic features and clinical course of disease. J Clin Oncol 1987; 5: 999-1006.
26. Walker RA, Gullick WJ, Varley JM. An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer. Br J Cancer 1989; 60: 426-9.
27. Tsuda H, Hirohashi S, Shimosato Y, et al. Correlation between long term survival in breast cancer patients and amplification of two putative oncogene-coamplification units : hst-1 / int-2 and c-erbB-2 / ear-1. Cancer Res 1989; 49: 3164-08.
28. Zhou D-J, Ahuja H, Cline MJ. Proto-oncogene abnormalities in human breast cancer : c-erbB-2 amplification does not correlate with recurrence of disease. Oncogene 1989; 4: 105-8.
29. Van de Vijver MJ, Peterse JL, Mooi WJ, et al. Neu-protein overexpressionin in breast cancer. N Engl J Med 1988; 319: 1239-45.
30. Rilke F, Colnaghi MI, Cascinelli N, et al. Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Int J Cancer 1991; 49: 44-9.
31. Barnes DM, Lammie GA, Millis RR, Gullick WJ, Allen DS, Altman DG. An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinomas. Br J Cancer 1988; 58: 448-52.
32. King CR, Swain SM, Porter L, Steinberg SM, Lippman ME, Gelmann EP. Heterogeneous expression of c-erbB-2 messenger RNA in human breast cancer. Cancer Res 1989; 49: 4185-91.
33. Adnane J, Gaudray P, Simon M-P, Simony-Lafontaine J, Jeanteur P, Theillet C. Proto-oncogene amplification and breast tumour phenotype. Oncogene 1989; 4: 1389-95.
34. Tavassoli M, Quirke P, Farzaneh F, Lock NJ, Mayne LV, Kirkham N. c-erbB-2 / c-erbA coamplification indicative of lymph node metastasis and c-myc amplification of high tumour grade, in human breast cancer. Br J Cancer 1989; 60: 505-10.
35. Guerin M, Gabillot M, Mathieu M-C, et al. Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance. Int J Cancer 1989; 43: 201-8.
36. Berger MS, Locher GW, Saurer S, et al. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 1988; 48: 1238-43.
37. Zeillinger R, Kury F, Czerwenka K, et al. HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer. Oncogene 1989; 4: 109-14.
38. Paik S, Hazan R, Fisher ER, et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. J Clin Oncol 1990; 8: 103-12.
39. Gullick WJ, Love SB, Wright C, et al. c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br J Cancer 1991; 63: 434-8.
40. Lacroix H, Iglehart JD, Skinner MA, Kraus MH. Overexpression of c-erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases. Oncogene 1989; 4: 145-51.